Daniel J Renouf
BC Cancer · BC Cancer - Vancouver · BCCA - Vancouver Cancer Centre, Vancouver BC, Canada
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Daniel J Renouf as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:59 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06574620 · Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to TreatmentBritish Columbia Cancer Agency · recruiting · Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph1/Ph2NCT03450018 · A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIXBritish Columbia Cancer Agency · terminated · Metastatic Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT03297606 · Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)Canadian Cancer Trials Group · recruiting · Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors · study chair
- Ph1NCT03217253 · Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionNational Cancer Institute (NCI) · withdrawn · Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma, Metastatic Malignant Solid Neoplasm · principal investigator
- Ph2NCT02978547 · The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal AdenocarcinomaBritish Columbia Cancer Agency · unknown · Resectable Pancreatic Ductal Adenocarcinoma · principal investigator
- N/ANCT02869802 · Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic AnalysisBritish Columbia Cancer Agency · recruiting · Cancer, Pancreatic Cancer · principal investigator
- Ph2NCT02651415 · Phase II Study of Perindopril and Regorafenib in mCRCBritish Columbia Cancer Agency · completed · Metastatic Colorectal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- North American Star ConsortiumUM1CA186644 · NCI · UNIVERSITY HEALTH NETWORK · PI Philippe Bedard, Kevin D Courtney, Steven Grant, Salma Jabbour, Jeffrey Lancet, Devalingam Mahalingam, Lillian L Siu, JONATHAN C TRENT · fiscal years 2014 to 2026Named on NCT03217253
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.